Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial. (nature.com)

Authors: Croese T … Schwartz M Journal: Nature Medicine Published: 2026-07-15 DOI: https://doi.org/10.1038/s41591-026-04547-8